Potential of mHealth Technology for Management of Diabetes and Cardiovascular Comorbidities in Rural Bangladesh: A Narrative Review
Main Article Content
Abstract
Background: Diabetes is becoming a common condition in LMICs, alongside cardiovascular disease (CVD). Distance and lack of staff, referral system, diagnostics and medicines access are an extra obstacle for the rural people. Mobile health (mHealth) can offer additional extension of prevention and chronic disease management, but only as long as it is integrated with the ebb and flow of an existing primary care system.
Objective: Summarize evidence up to 31 December 2020 regarding mHealth and type 2 diabetes (T2D) and cardiovascular (CV) comorbidity in rural, resource-limited settings, and to draw implications for Bangladesh.
Methods: Evidence was identified until 31 December 2020 using targeted search strategies in PubMed/MEDLINE, Scopus, Google Scholar, WHO resources and reference lists. Sources of full text information were considered, including freely available sources which focused on randomized trials, systematic reviews and meta-analyses, major observational studies and authoritative guidance. Evidence was aligned by prevention, diabetes self-management, hypertension/CVD management, CHW decision support, and implementation barriers. This was a narrative, non-exhaustive synthesis – no new pooled estimate was made.
Results: Prior to 2021, there were some indications of minimal improvement in intermediate outcomes such as HbA1c, blood pressure, adherence, health behaviors, and treatment processes. SMS trials for diabetes prevention in India showed mixed results and meta-analyses showed modest reductions in HbA1c. Selected cardiovascular text-messaging studies showed improvement in risk factors and outcomes related to adherence. Rural CHW decision-support trials in India and Tibet/China enhanced risk assessment, referral, medication utilization, or treatment processes, with mixed outcomes for blood-pressure, and downstream care constraints reducing the clinical impact.
Conclusions: mHealth needs to be considered as an additional and supporting service within a working primary care service and not as a standalone treatment. Low bandwidth, multilingual, offline-capable tools coupled with CHWs, standardised protocols, access to medicines and effective referral mechanisms are sensible design considerations for Bangladesh and similar contexts and need to be evaluated in advance and implemented on a local basis considering both effectiveness and cost-effectiveness, as well as equity.
Downloads
Article Details
References
diabetes prevalence estimates for 2019 and projections
for 2030 and 2045: Results from the International Diabetes
Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract.
2019;157:107843. doi:10.1016/j.diabres.2019.107843.
[2] Roth GA, Mensah GA, Johnson CO, et al. Global burden of
cardiovascular diseases and risk factors, 1990-2019: Update from
the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982-3021.
doi:10.1016/j.jacc.2020.11.010.
[3] Manne-Goehler J, Geldsetzer P, Agoudavi K, et al. Health
system performance for people with diabetes in 28 low- and
middle-income countries: A cross-sectional study of nationally
representative surveys. PLoS Med. 2019;16(3):e1002751.
doi:10.1371/journal.pmed.1002751.
[4] Geldsetzer P, Manne-Goehler J, Marcus ME, et al. The state
of hypertension care in 44 low-income and middle-income
countries: a cross-sectional study of nationally representative
individual-level data from 1.1 million adults. Lancet.
2019;394(10199):652-662. doi:10.1016/S0140-6736(19)30955-9.
[5] World Health Organization. WHO Package of Essential
Noncommunicable (PEN) Disease Interventions for Primary
Health Care. Geneva: World Health Organization; 2020. ISBN
978-92-4-000922-6.
[6] American Diabetes Association. 10. Cardiovascular disease and
risk management: Standards of Medical Care in Diabetes-2020.
Diabetes Care. 2020;43(Suppl 1):S111-S134. doi:10.2337/dc20-
S010.Cardiovascular Disease Management in Primary Health Care.
Geneva: World Health Organization; 2016. ISBN 978-92-4-
151137-7.
[8] World Health Organization. WHO Guideline: Recommendations
on Digital Interventions for Health System Strengthening.
Geneva: World Health Organization; 2019. ISBN 978-92-4-
155050-5.
[9] Labrique AB, Vasudevan L, Kochi E, Fabricant R, Mehl G. mHealth
innovations as health system strengthening tools: 12 common
applications and a visual framework. Glob Health Sci Pract.
2013;1(2):160-171. doi:10.9745/GHSP-D-13-00031.
[10] Free C, Phillips G, Watson L, et al. The effectiveness of mobilehealth
technologies to improve health care service delivery
processes: a systematic review and meta-analysis. PLoS Med.
2013;10(1):e1001363. doi:10.1371/journal.pmed.1001363.
[11] Beratarrechea A, Lee AG, Willner JM, Jahangir E, Ciapponi A,
Rubinstein A. The impact of mobile health interventions on
chronic disease outcomes in developing countries: a systematic
review. Telemed J E Health. 2014;20(1):75-82. doi:10.1089/
tmj.2012.0328.
[12] Peiris D, Praveen D, Johnson C, Mogulluru K. Use of mHealth
systems and tools for non-communicable diseases in low- and
middle-income countries: a systematic review. J Cardiovasc
Transl Res. 2014;7(8):677-691. doi:10.1007/s12265-014-9581-5.
[13] Bloomfield GS, Vedanthan R, Vasudevan L, Kithei A, Were M,
Velazquez EJ. Mobile health for non-communicable diseases
in Sub-Saharan Africa: a systematic review of the literature and
strategic framework for research. Global Health. 2014;10:49.
doi:10.1186/1744-8603-10-49.
[14] Aranda-Jan CB, Mohutsiwa-Dibe N, Loukanova S. Systematic
review on what works, what does not work and why of
implementation of mobile health (mHealth) projects in Africa.
BMC Public Health. 2014;14:188. doi:10.1186/1471-2458-14-188.
[15] 15. Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS.
Impact of mHealth chronic disease management on treatment
adherence and patient outcomes: a systematic review. J Med
Internet Res. 2015;17(2):e52. doi:10.2196/jmir.3951.
[16] Agarwal S, Perry HB, Long LA, Labrique AB. Evidence on
feasibility and effective use of mHealth strategies by frontline
health workers in developing countries: systematic review. Trop
Med Int Health. 2015;20(8):1003-1014. doi:10.1111/tmi.12525.
[17] Buss VH, Leesong S, Barr M, Varnfield M, Harris M. Primary
prevention of cardiovascular disease and type 2 diabetes
mellitus using mobile health technology: systematic review
of the literature. J Med Internet Res. 2020;22(10):e21159.
doi:10.2196/21159.
[18] Ramachandran A, Snehalatha C, Ram J, et al. Effectiveness of
mobile phone messaging in prevention of type 2 diabetes by
lifestyle modification in men in India: a prospective, parallelgroup,
randomised controlled trial. Lancet Diabetes Endocrinol.
2013;1(3):191-198. doi:10.1016/S2213-8587(13)70067-6.
[19] Nanditha A, Snehalatha C, Raghavan A, et al. The posttrial
analysis of the Indian SMS diabetes prevention study
shows persistent beneficial effects of lifestyle intervention.
Diabetes Res Clin Pract. 2018;142:213-221. doi:10.1016/j.
diabres.2018.05.042.
[20] Nanditha A, Thomson H, Susairaj P, et al. A pragmatic and
scalable strategy using mobile technology to promote
sustained lifestyle changes to prevent type 2 diabetes in
India and the UK: a randomised controlled trial. Diabetologia.
2020;63(3):486-496. doi:10.1007/s00125-019-05061-y.
[21] Pfammatter A, Spring B, Saligram N, et al. mHealth intervention
to improve diabetes risk behaviors in India: a prospective,
parallel group cohort study. J Med Internet Res. 2016;18(8):e207.
doi:10.2196/jmir.5712.
[22] Saffari M, Ghanizadeh G, Koenig HG. Health education via
mobile text messaging for glycemic control in adults with
type 2 diabetes: a systematic review and meta-analysis. Prim
Care Diabetes. 2014;8(4):275-285. doi:10.1016/j.pcd.2014.03.004.
[23] Haider R, Sudini L, Chow CK, Cheung NW. Mobile phone
text messaging in improving glycaemic control for patients
with type 2 diabetes mellitus: a systematic review and metaanalysis.
Diabetes Res Clin Pract. 2019;150:27-37. doi:10.1016/j.
diabres.2019.02.022.
[24] Hou C, Carter B, Hewitt J, et al. Do mobile phone applications
improve glycemic control (HbA1c) in the self-management of
diabetes? A systematic review, meta-analysis, and GRADE of
14 randomized trials. Diabetes Care. 2016;39(11):2089-2095.
doi:10.2337/dc16-0346.
[25] Bonoto BC, de Araujo VE, Godoi IP, et al. Efficacy of mobile
apps to support the care of patients with diabetes mellitus: a
systematic review and meta-analysis of randomized controlled
trials. JMIR Mhealth Uhealth. 2017;5(3):e4. doi:10.2196/
mhealth.6309.
[26] Kumar D, Raina S, Sharma SB, Raina SK, Bhardwaj AK.
Effectiveness of randomized control trial of mobile phone
messages on control of fasting blood glucose in patients with
type-2 diabetes mellitus in a Northern State of India. Indian J
Public Health. 2018;62(3):224-226. doi:10.4103/ijph.IJPH_199_17.
[27] Vinitha R, Nanditha A, Snehalatha C, et al. Effectiveness of mobile
phone text messaging in improving glycaemic control among
persons with newly detected type 2 diabetes. Diabetes Res
Clin Pract. 2019;158:107919. doi:10.1016/j.diabres.2019.107919.
[28] Liu K, Xie Z, Or CK. Effectiveness of mobile app-assisted selfcare
interventions for improving patient outcomes in type 2
diabetes and/or hypertension: systematic review and metaanalysis
of randomized controlled trials. JMIR Mhealth Uhealth.
2020;8(8):e15779. doi:10.2196/15779.
[29] Mao Y, Lin W, Wen J, Chen G. Impact and efficacy of mobile
health intervention in the management of diabetes and
hypertension: a systematic review and meta-analysis. BMJ Open
Diabetes Res Care. 2020;8(1):e001225. doi:10.1136/bmjdQrc-
2020-001225.
[30] Bobrow K, Farmer AJ, Springer D, et al. Mobile phone text
messages to support treatment adherence in adults with
high blood pressure (SMS-Text Adherence Support [StAR]): a
single-blind, randomized trial. Circulation. 2016;133(6):592-600.doi:10.1161/CIRCULATIONAHA.115.017530.
[31] Omboni S, Caserini M, Coronetti C. Telemedicine and M-health
in hypertension management: technologies, applications
and clinical evidence. High Blood Press Cardiovasc Prev.
2016;23(3):187-196. doi:10.1007/s40292-016-0143-6.
[32] Chow CK, Redfern J, Hillis GS, et al. Effect of lifestyle-focused
text messaging on risk factor modification in patients with
coronary heart disease: a randomized clinical trial. JAMA.
2015;314(12):1255-1263. doi:10.1001/jama.2015.10945.
[33] Pfaeffli Dale L, Whittaker R, Jiang Y, Stewart R, Rolleston A,
Maddison R. Text message and internet support for coronary
heart disease self-management: results from the Text4Heart
randomized controlled trial. J Med Internet Res. 2015;17(10):e237.
doi:10.2196/jmir.4944.
[34] Widmer RJ, Collins NM, Collins CS, West CP, Lerman LO, Lerman A.Digital health interventions for the prevention of cardiovascular
disease: a systematic review and meta-analysis. Mayo Clin Proc.
2015;90(4):469-480. doi:10.1016/j.mayocp.2014.12.026.
[35] Gandhi S, Chen S, Hong L, et al. Effect of mobile health
interventions on the secondary prevention of cardiovascular
disease: systematic review and meta-analysis. Can J Cardiol.
2017;33(2):219-231. doi:10.1016/j.cjca.2016.08.017.
[36] Unal E, Giakoumidakis K, Khan E, Patelarou E. Mobile phone
text messaging for improving secondary prevention in
cardiovascular diseases: a systematic review. Heart Lung.
2018;47(4):351-359. doi:10.1016/j.hrtlng.2018.05.009.
[37] Hamilton SJ, Mills B, Birch EM, Thompson SC. Smartphones
in the secondary prevention of cardiovascular disease: a
systematic review. BMC Cardiovasc Disord. 2018;18(1):25.
doi:10.1186/s12872-018-0764-x.
[38] Praveen D, Patel A, Raghu A, et al. SMARTHealth India:
development and field evaluation of a mobile clinical decision
support system for cardiovascular diseases in rural India. JMIR
Mhealth Uhealth. 2014;2(4):e54. doi:10.2196/mhealth.3568.
[39] Tian M, Ajay VS, Dunzhu D, et al. A cluster-randomized,
controlled trial of a simplified multifaceted management
program for individuals at high cardiovascular risk (SimCard
Trial) in rural Tibet, China, and Haryana, India. Circulation.
2015;132(9):815-824. doi:10.1161/CIRCULATIONAHA.115.015373.
[40] Peiris D, Praveen D, Mogulluru K, et al. SMARThealth India:
a stepped-wedge, cluster randomised controlled trial of a
community health worker managed mobile health intervention
for people assessed at high cardiovascular disease risk in rural
India. PLoS One. 2019;14(3):e0213708. doi:10.1371/journal.
pone.0213708.
[7] World Health Organization. HEARTS: Technical Package for